Camptothecin-7-Ethylamine Derivatives for Solubility and Toxicity Balance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Camptothecin-based antitumor drugs suffer from toxicity, poor solubility, and the development of drug resistance by tumor cells, limiting their effectiveness in treating cancers such as gastric cancer, esophageal cancer, and lung cancer.
Innovation Solution
Development of camptothecin-7-ethylamine derivatives with improved solubility and enhanced antitumor activity, achieved through various synthesis routes involving reactions with amines and specific intermediates, resulting in compounds with enhanced therapeutic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If camptothecin-based antitumor drugs are used, then significant therapeutic effects on various cancers are achieved, but toxicity and poor solubility limit their effectiveness
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of camptothecin at the 7-position through various substitutions (ethylamine derivatives with different R groups). These structural parameter changes improve solubility and reduce toxicity while maintaining antitumor activity, directly resolving the contradiction between therapeutic effect and harmful factors
Solution Approach 2:
The invention creates composite chemical structures by combining the camptothecin core with various ethylamine derivative groups (containing heteroatoms like N, O, F, Cl). This composite approach enhances the drug's pharmaceutical properties including solubility and safety profile while preserving the antitumor mechanism, thus resolving the toxicity-solubility contradiction
2Reliability
If camptothecin derivatives are developed to improve solubility, then therapeutic potential is enhanced, but complexity of synthesis increases
Solution Approach 1:
The synthesis is segmented into modular steps: first preparing substituted anilines, then converting to halopropiophenones, followed by condensation with the camptothecin core. This segmentation allows systematic optimization of each step and simplifies the overall synthetic complexity while achieving the desired solubility and activity improvements
Solution Approach 2:
The patent uses well-defined intermediate compounds (substituted anilines, halopropiophenones) as mediators in the synthesis pathway. These intermediaries serve as versatile building blocks that can be prepared once and used to generate multiple final derivatives, reducing overall synthesis complexity while maintaining product quality
3Reliability
If traditional camptothecin drugs are administered, then antitumor activity is achieved, but drug resistance by tumor cells develops
Solution Approach 1:
By changing the chemical parameters at the 7-position of camptothecin (introducing ethylamine derivatives with various heteroatomic groups), the patent creates structurally diverse analogs that maintain the topoisomerase inhibition mechanism while evading resistance mechanisms developed against traditional camptothecin, thus preserving antitumor activity stability
Data Source
AI summary
The present invention provides a camptothecin-7-ethylamine derivative or a pharmaceutically acceptable salt thereof, a stereoisomer thereof or a prodrug thereof, a preparation method therefor, and use thereof. The camptothecin-7-ethylamine derivative has a structure represented by formula (1).